It will be important to evaluate peak serum levels of hu14.18-IL2 as well as monitor anti-IL2 and anti-linker responses to determine if CAHA+ sera affect antibody-mediated cellular cytotoxicity, as seen in some humans receiving IC treatment [44]. This evidence concerns the gene IL2 and autoimmune hemolytic anemia, cold type.